Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 15, Issue 720, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2023-11-01
DOI
10.1126/scitranslmed.adi1617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy
- (2023) Yazhe Wang et al. Science Advances
- Intrathecal delivery and its applications in leptomeningeal disease
- (2022) Minsoo Khang et al. ADVANCED DRUG DELIVERY REVIEWS
- Meningeal macrophages protect against viral neuroinfection
- (2022) Julie Rebejac et al. IMMUNITY
- Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid
- (2022) Antoine Drieu et al. NATURE
- An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity
- (2021) Harrison Naung et al. JOURNAL OF NEURO-ONCOLOGY
- Nonsurgical treatment of skin cancer with local delivery of bioadhesive nanoparticles
- (2021) Jamie K. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized phase II trial of veliparib, radiotherapy and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
- (2021) Hao-Wen Sim et al. NEURO-ONCOLOGY
- Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
- (2021) Jessica Buck et al. Frontiers in Molecular Biosciences
- Clearance of two organic nanoparticles from the brain via the paravascular pathway
- (2020) Xiao Gu et al. JOURNAL OF CONTROLLED RELEASE
- Phase II study of reduced‐dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium
- (2020) Keiko Okada et al. PEDIATRIC BLOOD & CANCER
- Poly(ADP-ribose) polymerase inhibition: past, present and future
- (2020) Nicola J. Curtin et al. NATURE REVIEWS DRUG DISCOVERY
- PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity
- (2019) Shiv K. Gupta et al. Frontiers in Oncology
- Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors
- (2019) Neeta Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma
- (2019) Paige Baldwin et al. Frontiers in Oncology
- Crossing the blood-brain barrier with nanoparticles
- (2018) Yiqun Zhou et al. JOURNAL OF CONTROLLED RELEASE
- Differential patterns of metastatic dissemination across medulloblastoma subgroups
- (2018) Michal Zapotocky et al. Journal of Neurosurgery-Pediatrics
- Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy
- (2018) Yanxin Lu et al. PHARMACOLOGY & THERAPEUTICS
- PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow
- (2018) Todd A. Hopkins et al. MOLECULAR CANCER RESEARCH
- A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma
- (2017) Kim Kramer et al. PEDIATRIC BLOOD & CANCER
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Surface chemistry governs cellular tropism of nanoparticles in the brain
- (2017) Eric Song et al. Nature Communications
- Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies
- (2017) Paul Lesueur et al. Oncotarget
- Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young Children
- (2016) B.H. Kann et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors
- (2016) Jennifer K. Saucier-Sawyer et al. JOURNAL OF CONTROLLED RELEASE
- Survival After Relapse of Medulloblastoma
- (2016) Carl Koschmann et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Improved i.p. drug delivery with bioadhesive nanoparticles
- (2016) Yang Deng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Systemic delivery of blood–brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue
- (2015) Jennifer K. Saucier-Sawyer et al. JOURNAL OF DRUG TARGETING
- A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
- (2015) Aleksanteri Aspelund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- A sunblock based on bioadhesive nanoparticles
- (2015) Yang Deng et al. NATURE MATERIALS
- A holistic approach to targeting disease with polymeric nanoparticles
- (2015) Christopher J. Cheng et al. NATURE REVIEWS DRUG DISCOVERY
- Intraventricular Delivery of siRNA Nanoparticles to the Central Nervous System
- (2015) Rishab Shyam et al. Molecular Therapy-Nucleic Acids
- PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
- (2015) Dannis Gilbert Van Vuurden et al. Oncotarget
- The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles
- (2014) Yang Deng et al. BIOMATERIALS
- A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†
- (2014) Jack M. Su et al. NEURO-ONCOLOGY
- PLA-PEG-PLA copolymer-based polymersomes as nanocarriers for delivery of hydrophilic and hydrophobic drugs: preparation and evaluation with atorvastatin and lisinopril
- (2013) H. Danafar et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Brain-wide pathway for waste clearance captured by contrast-enhanced MRI
- (2013) Jeffrey J. Iliff et al. JOURNAL OF CLINICAL INVESTIGATION
- Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
- (2013) J. Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- PET imaging with 89Zr: From radiochemistry to the clinic
- (2012) Melissa A. Deri et al. NUCLEAR MEDICINE AND BIOLOGY
- A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid
- (2012) J. J. Iliff et al. Science Translational Medicine
- Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
- (2011) Carl D. Walkey et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- In vivo biodistribution and accumulation of 89Zr in mice
- (2011) Diane S. Abou et al. NUCLEAR MEDICINE AND BIOLOGY
- Polylactide nanoparticles containing stably incorporated cyanine dyes for in vitro and in vivo imaging applications
- (2010) Rong Tong et al. MICROSCOPY RESEARCH AND TECHNIQUE
- Medulloblastoma in young children
- (2010) Stefan Rutkowski et al. PEDIATRIC BLOOD & CANCER
- The Origins of Medulloblastoma Subtypes
- (2008) Richard J. Gilbertson et al. Annual Review of Pathology-Mechanisms of Disease
- Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
- (2008) Wim H. De Jong et al. BIOMATERIALS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started